---

---

tags : Europe    symbols : NVS   

save search

---

Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth - Technavio
Published: 2024-01-16 (Crawled : 03:00) - prnewswire.com
VTRS | News A | $11.36 0.98% 0.97% 210 |

Health Technology

| -2.74% | O: -0.6% H: 1.34% C: 1.21%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| -7.99% | O: 0.16% H: 0.43% C: 0.07%
europe growth market

---

Sandoz receives European Commission approval for Tyruko® (natalizumab), first and only biosimilar for multiple sclerosis in Europe
Published: 2023-09-26 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 11.68% | O: -3.05% H: 1.75% C: 0.5%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| -2.9% | O: -0.07% H: 0.46% C: -0.31%
tyruko europe biosimilar approval sclerosis

---

Heparin Market to grow by USD 3.01 billion from 2022 to 2027, Europe to account for 39% of market growth- Technavio
Published: 2023-09-11 (Crawled : 03:00) - prnewswire.com
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 0.53% | O: 0.32% H: 0.77% C: 0.6%
BAX | $40.655 -0.89% 44K |

Health Technology

| 6.08% | O: 0.67% H: 0.54% C: -0.59%
SNY | News | $47.69 1.15% 1.13% 1.1K |

Health Technology

| -11.99% | O: 1.65% H: 0.0% C: 0.0%
europe market

---

Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0 |

Health Technology

| 2.68% | O: -4.57% H: 0.22% C: -1.98%
SNYNF | News | $94.25 1.67% -2.18% 0 |

Health Technology

| -16.59% | O: -1.46% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 10.34% | O: 0.0% H: 0.0% C: 0.0%
VTRS | News A | $11.36 0.98% 0.97% 210 |

Health Technology

| 23.75% | O: 0.22% H: 0.65% C: -1.09%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| -4.98% | O: 0.62% H: 0.0% C: -2.04%
JNJ | News | $149.56 0.3% 0.03% 140K |

Health Technology

| -9.4% | O: -0.66% H: 0.18% C: -0.9%
GSK | News | $41.24 1.6% 0.0% 1.6K |

Health Technology

| 11.73% | O: -0.03% H: 0.3% C: -2.63%
SNY | News | $47.69 1.15% 1.13% 1.1K |

Health Technology

| -18.13% | O: 0.53% H: 0.0% C: 0.0%
CNTG | $0.48 2.11% 6.73% 0 |

Commercial Services

| -70.55% | O: 1.23% H: 27.27% C: -15.76%
europe report dementia trials research growing market

---

Biosimilars market size to increase by USD 42,227.12 million: Europe to contribute 46% of market growth - Technavio
Published: 2022-12-08 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 0 |

Health Technology

| -0.84% | O: -0.89% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 26.59% | O: 0.55% H: 0.39% C: 0.39%
VTRS | News A | $11.36 0.98% 0.97% 210 |

Health Technology

| 3.65% | O: 0.0% H: 0.82% C: -1.64%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 7.95% | O: 0.24% H: 0.32% C: -0.93%
ABBV | News | $168.48 -0.63% 110K |

Health Technology

| 2.14% | O: 0.46% H: 0.59% C: -2.22%
SNY | News | $47.69 1.15% 1.13% 1.1K |

Health Technology

| 0.49% | O: -0.15% H: 0.0% C: 0.0%
BIIB | $200.31 3.69% 470K |

Health Technology

| -33.18% | O: 0.0% H: 1.34% C: -1.29%
AMGN | News | $270.69 -1.04% 120K |

Health Technology

| -4.21% | O: -0.48% H: 0.35% C: -1.95%
europe growth market

---

Lyophilization equipment and services market to grow by USD 2.13 Bn, 33% of the growth to originate from Europe - Technavio
Published: 2022-10-31 (Crawled : 14:20) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 0 |

Health Technology

| 11.16% | O: 2.76% H: 0.0% C: -5.14%
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 47.47% | O: 0.35% H: 0.0% C: -0.1%
TMO | News | $574.59 4.78% 1.29% 12K |

Health Technology

| 11.8% | O: -0.7% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 22.41% | O: -0.38% H: 0.92% C: 0.85%
BAX | $40.655 -0.89% 44K |

Health Technology

| -25.42% | O: -0.22% H: 0.31% C: -0.97%
SNY | News | $47.69 1.15% 1.13% 1.1K |

Health Technology

| 9.81% | O: 0.57% H: 0.0% C: 0.0%
europe services growth market

---

Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published: 2022-06-24 (Crawled : 09:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 21K |

Health Technology

| -39.7% | O: 0.99% H: 0.0% C: -0.5%
GLAXF | News | $19.54 -3.77% 0 |

Health Technology

| -24.94% | O: 3.19% H: 2.28% C: -1.81%
SNYNF | News | $94.25 1.67% -2.18% 0 |

Health Technology

| -2.58% | O: 8.01% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 46.19% | O: 6.71% H: 0.0% C: -0.1%
ALPMY | News | $9.49 -0.42% 55K |

Manufacturing

| -40.39% | O: 4.33% H: 0.0% C: -2.44%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 21.17% | O: 2.38% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 1.6K |

Health Technology

| -22.83% | O: 1.26% H: 0.95% C: 0.92%
ABBV | News | $168.48 -0.63% 110K |

Health Technology

| 14.24% | O: 1.57% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.1K |

Health Technology

| -7.11% | O: 3.49% H: 0.0% C: 0.0%
GLMD | $0.3614 -0.74% -0.41% 100 |

Health Technology

| -99.68% | O: 1.21% H: 0.0% C: -3.5%
AMGN | News | $270.69 -1.04% 120K |

Health Technology

| 12.53% | O: 0.37% H: 0.82% C: 0.56%
europe growth market drug

---

Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 12.19% | O: -0.31% H: 0.53% C: -0.19%
GSK | News | $41.24 1.6% 0.0% 1.6K |

Health Technology

| -7.47% | O: -0.43% H: 0.0% C: 0.0%
BHC | $8.555 0.29% 37K |

Health Technology

| -22.81% | O: -0.72% H: 1.09% C: -9.3%
ABBV | News | $168.48 -0.63% 110K |

Health Technology

| 9.35% | O: -0.17% H: 0.59% C: -1.52%
ACAD | News | $16.75 0.06% 16K |

Health Technology

| -2.56% | O: -3.61% H: 1.39% C: -3.14%
europe disease growth market

---

Global Report on Europe precision medicine Market Size & Share Worth USD 27469 Million, to Record a 10.7% CAGR by 2028 | Europe precision medicine Industry Trends, Segmentation, Analysis & Forecast by Zion Market Research
Published: 2022-05-16 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $140.3 1.13% 0 |

Health Technology

| 11.51% | O: 1.73% H: 0.86% C: -1.11%
TMO | News | $574.59 4.78% 1.29% 12K |

Health Technology

| 4.44% | O: -0.22% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 15.19% | O: 1.04% H: 0.0% C: 0.0%
MDT | $81.29 0.89% 0.26% 2.1K |

Health Technology

| -20.51% | O: -0.25% H: 2.28% C: 1.77%
LH M | $207.97 2.41% 0.0% 1 |

Health Services

| -16.59% | O: -0.59% H: 0.58% C: -0.32%
AZN | News | $71.19 0.48% 1M |

Health Technology

| 13.32% | O: 1.52% H: 0.0% C: 0.0%
europe research report market

---

Cancer Therapies Market size in Europe to Grow by USD 34.71 billion | Technavio
Published: 2022-04-02 (Crawled : 04:20) - prnewswire.com
AMGN | News | $270.69 -1.04% 120K |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.19 0.48% 1M |

Health Technology

| Email alert Add to watchlist
GSK | News | $41.24 1.6% 0.0% 1.6K |

Health Technology

| Email alert Add to watchlist
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -3.77% 0 |

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 1.13% 0 |

Health Technology

| Email alert Add to watchlist
europe cancer market therapy

---

Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in Europe
Published: 2022-03-25 (Crawled : 12:20) - globenewswire.com
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 15.01% | O: 1.14% H: 0.0% C: 0.0%
kymriah novartis europe car-t positive therapy chmp t-cell

---

Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine
Published: 2022-02-18 (Crawled : 07:00) - globenewswire.com
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 14.01% | O: -0.23% H: 0.0% C: -0.9%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 14.08% | O: 0.02% H: 0.36% C: -0.33%
europe ces

---

Diabetic Neuropathy Drugs Market: Segmentation by product (calcium channel alpha-2-delta ligand, SNRIs and TCAs, and others) and geography (North America, Europe, Asia, and ROW)--Forecast till 2025|Technavio
Published: 2022-02-07 (Crawled : 10:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 21K |

Health Technology

| -43.35% | O: 7.04% H: 0.0% C: -5.13%
AZNCF | News | $140.3 1.13% 0 |

Health Technology

| 26.93% | O: 2.69% H: 0.5% C: -1.76%
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 12.72% | O: 1.0% H: 0.59% C: 0.59%
ALPMY | News | $9.49 -0.42% 55K |

Manufacturing

| -45.18% | O: 1.1% H: 0.69% C: 0.0%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 14.67% | O: 1.03% H: 0.0% C: 0.0%
AZN | News | $71.19 0.48% 1M |

Health Technology

| 25.91% | O: -0.14% H: 1.01% C: 0.87%
america europe drug diabetic diabetes

---

Novartis initiates new USD 15 billion share buyback highlighting confidence in growth and pipeline
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 20.2% | O: 6.92% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 22.46% | O: 5.97% H: 0.0% C: 0.0%
novartis growth

---

Endo Begins Shipment of Generic MIACALCIN® (calcitonin salmon) Injection
Published: 2021-11-18 (Crawled : 13:30) - biospace.com/
NVSEF | News | $96.0 0.94% 0 |

Health Technology

| 17.94% | O: -0.53% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 20.77% | O: 0.1% H: 0.31% C: 0.04%
ENDP | News | $0.2926 -9.6% |

Health Technology

| -95.59% | O: 1.51% H: 0.0% C: -6.84%
miacalcin injection

---

Sandoz announces plans to further strengthen its antibiotics manufacturing setup in Europe
Published: 2021-05-18 (Crawled : 09:00) - globenewswire.com
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 11.64% | O: 0.1% H: 0.41% C: 0.07%
europe antibiotics iot

---

Novartis CEO Says Remote Work Hybrid Should Mean Access to New Talent Pools
Published: 2021-04-28 (Crawled : 17:00) - biospace.com/
NVS | News | $97.28 2.27% 1.47% 190K |

Health Technology

| 14.1% | O: -0.37% H: 0.7% C: 0.58%
ceo leo

---

Gainers vs Losers

71%

29%

Top 10 Gainers

CZOO | $9.98 100.0% 330K |

AMST | $3.48 74.0% 21M |

Technology Services

BOF | $1.78 52.14% 15M |

CSSE 4 | $0.2184 43.4% 36M |

Consumer Services

ACB | $7.32 16.56% 780K |

Process Industries

AEYE | $15.42 14.39% 150K |

Technology Services

BACK | $3.75 13.64% 44K |

Health Care and Social Assistan...

CGC | $8.835 12.55% 740K |

Process Industries

BW | News | $1.0002 9.05% 190K |

Electronic Technology

BILI | $12.525 9.01% 3.5M |

Technology Services

---

Your saved searches

---